Search Results 41-50 of 117 for ❗토지노추천 【위너보증.com / 가입코드 9122】 원벳원계열 ❗

  1. Study of BLU-667 in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  2. Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to ...

  3. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  4. Publications - Dong Chen, M.D., Ph.D. - Mayo Clinic

    He R, Chen D. Myelodysplastic neoplasm with biallelic TP53 inactivation in a patient with plasma cell myeloma after cytotoxic therapy. Blood.

  5. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

    The purpose of this study is to determine how well paclitaxel with and without nivolumab works in treating patients with soft tissue sarcoma that have not ...

  6. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  7. Px Code,Supply #,Description,Unit Price 278000024,48589,CATH ABL THRMCL ST FJ,"5,504.00" 278000025,55648,CATH ABL CLS NON-NAV 6FX4,"1,312.00" 278000026 ...

  8. A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to ...

  9. Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  10. ... NO CELL SELECT,1174,#N/A,1245.00 300000078,HC CHIMERISM ANLYS W CELL SELECT,997,#N/A,1058.00 300000079,HC CHROMOSOMAL MICROARRAY TUMOR,1397,#N/A,1482.00 ...